—SWK
— • —
$71.83
P/E
27.15
PEG
—
FCF Yield
—
Rev Growth YoY
-140.0% YoY
Gross Margin
3066.0%
Health Score
5/10
D/E Ratio
0.65
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this data payload, making it impossible to describe the company's business, products, or competitive position with certainty. Based on available metrics — a Price/Sales ratio of 0.74x and a Price/Book of 1.32x — the stock appears to be a moderately sized enterprise, though market capitalisation data is unavailable, preventing a definitive cap-tier classification. Without sector or industry tags, the analysis below is necessarily anchored to the quantitative signals alone.
Financial Health
Score: 5/10
The balance sheet presents a mixed picture. On the positive side, the Debt/Equity ratio of 0.65x is manageable and the Return on Equity of 447.0% is extraordinarily high — a figure that, while eye-catching, may reflect accounting distortions such as minimal equity on the books rather than genuine operational superiority...
Risk Assessment
- DATA QUALITY: Gross margin of 3,066% and net margin of 266% are mathematically implausible for normal operations, strongly suggesting one-time items or reporting anomalies that make fundamental analysis unreliable.
- REVENUE DECLINE: Revenue growth of -140.0% YoY indicates a severe contraction or reversal, with no quarterly data available to assess whether a bottom has been reached.
- CASH FLOW: Free cash flow is unavailable, eliminating the ability to assess liquidity sustainability or the quality of reported earnings.
- TECHNICALS: A confirmed death cross (50-day MA below 200-day MA) combined with a bearish MACD signal indicates deteriorating price momentum.
- TRANSPARENCY: Multiple core data fields are absent (market cap, 52-week range, TTM revenue, TTM net income, FCF, price targets), limiting the depth of any credible analysis.
---...
**Score: 5/10** The balance sheet presents a mixed picture. On the positive side, the Debt/Equity ratio of 0.65x is manageable and the Return on Equity of 447.0% is extraordinarily high — a figure that, while eye-catching, may reflect accounting distortions such as minimal equity on the books rather than genuine operational superiority. The net margin of 266.0% and gross margin of 3,066.0% are statistically anomalous and almost certainly reflect non-operating income, asset gains, or one-time items rather than sustainable trading economics. Free cash flow is unavailable, which is a meaningful gap that prevents a complete assessment of the company's ability to self-fund operations. ---
- **DATA QUALITY: Gross margin of 3,066% and net margin of 266% are mathematically implausible for normal operations, strongly suggesting one-time items or reporting anomalies that make fundamental analysis unreliable.** - **REVENUE DECLINE: Revenue growth of -140.0% YoY indicates a severe contraction or reversal, with no quarterly data available to assess whether a bottom has been reached.** - **CASH FLOW: Free cash flow is unavailable, eliminating the ability to assess liquidity sustainability or the quality of reported earnings.** - **TECHNICALS: A confirmed death cross (50-day MA below 200-day MA) combined with a bearish MACD signal indicates deteriorating price momentum.** - **TRANSPARENCY: Multiple core data fields are absent (market cap, 52-week range, TTM revenue, TTM net income, FCF, price targets), limiting the depth of any credible analysis.** ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives